India’s first indigenously developed anti-malarial drug

Synriam is India’s first indigenously developed anti-malarial drug. It beats all currently available options on the counts of affordability, compliance and relief. The drug is the result of first successful public-private partnership on pharmaceutical research and development in India. Ranbaxy and the Ministry of Science paid Rs 5 crore each for the development of the drug.

National Dairy Plan

National Dairy Plan, which was launched on April 19, 2012, aims to increase the productivity of milch animals by adopting focused, scientific and systematic processes and help provide rural milk producers with greater access to the organized milk processing sector.

Leave a Reply

Your email address will not be published. Required fields are marked *